Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Adma Biologics Inc (NASDAQ: ADMA) was $18.50 for the day, up 6.63% from the previous closing price of $17.35. In other words, the price has increased by $6.63 from its previous closing price. On the day, 3.96 million shares were traded. ADMA stock price reached its highest trading level at $18.56 during the session, while it also had its lowest trading level at $17.8.
Ratios:
Our analysis of ADMA’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 42.40 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 55.09. For the most recent quarter (mrq), Quick Ratio is recorded 2.90 and its Current Ratio is at 5.97. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.23.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 22 ’24 when Tade Brad L. sold 15,000 shares for $21.15 per share. The transaction valued at 317,250 led to the insider holds 199,433 shares of the business.
Grossman Adam S sold 48,967 shares of ADMA for $1,033,204 on Nov 22 ’24. The President and CEO now owns 1,989,007 shares after completing the transaction at $21.10 per share. On Nov 22 ’24, another insider, Grossman Adam S, who serves as the Director and Officer of the company, bought 48,967 shares for $21.30 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 4377488384 and an Enterprise Value of 4356449280. As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.72, and their Forward P/E ratio for the next fiscal year is 18.62. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.73. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.25 while its Price-to-Book (P/B) ratio in mrq is 12.54. Its current Enterprise Value per Revenue stands at 10.216 whereas that against EBITDA is 29.612.
Stock Price History:
The Beta on a monthly basis for ADMA is 0.60, which has changed by 2.0730896 over the last 52 weeks, in comparison to a change of 0.087141395 over the same period for the S&P500. Over the past 52 weeks, ADMA has reached a high of $23.64, while it has fallen to a 52-week low of $5.88. The 50-Day Moving Average of the stock is 10.73%, while the 200-Day Moving Average is calculated to be 14.13%.
Shares Statistics:
ADMA traded an average of 2.45M shares per day over the past three months and 3552700 shares per day over the past ten days. A total of 236.62M shares are outstanding, with a floating share count of 228.00M. Insiders hold about 3.55% of the company’s shares, while institutions hold 86.69% stake in the company. Shares short for ADMA as of 1740700800 were 14225572 with a Short Ratio of 5.81, compared to 1738281600 on 13176851. Therefore, it implies a Short% of Shares Outstanding of 14225572 and a Short% of Float of 6.1899999999999995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
